Theratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021
Theratechnologies Inc. (THTX) announced it will report its Q1 fiscal 2021 financial results on April 14, 2021, ending February 28, 2021. A conference call will follow at 8:30 a.m. ET, hosted by CEO Paul Lévesque, to discuss these results. The call is open to financial analysts, while others can listen in. Participation details include toll-free and international dialing options, as well as a webcast link. An audio replay of the call will be available until April 21, 2021, with access codes provided for convenience.
- None.
- None.
MONTREAL, April 12, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies announced today that it will report its financial results for the first quarter of fiscal 2021 ended February 28, 2021 on Wednesday, April 14, 2021.
A conference call will be held on April 14, 2021 at 8:30 a.m. (ET) to discuss the results. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. The conference call will be open to questions from financial analysts. Media and other interested individuals are invited to participate in the call on a “listen-only” basis.
The conference call can be accessed by dialing 1-844-400-1697 (toll free) or 1-703-736-7400 (International). The conference call will also be accessible via webcast at https://edge.media-server.com/mmc/p/yiqvgmdq. Audio replay of the conference call will be available on the same day starting at 11:30 a.m. (ET) until April 21, 2021, by dialing 1-855-859-2056 (North America) or 1-404-537-3406 (International) and by entering the access code: 7982427. The audio replay is also available until April 14, 2022 on https://edge.media-server.com/mmc/p/yiqvgmdq.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For media inquiries:
Denis Boucher
Vice President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
617-356-1009
ir@theratech.com
FAQ
When will Theratechnologies report its Q1 fiscal 2021 financial results?
What time is the conference call for Theratechnologies' financial results?
Who will host the conference call for Theratechnologies?
How can I listen to Theratechnologies' conference call?
Is there a replay available for Theratechnologies' conference call?
